These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7529597)

  • 21. [Effect of human alpha2-macroglobulin on proliferative activity of rat tumor cells].
    Mal'tseva NV; Arkhipova SV; Zorin NA
    Tsitologiia; 1998; 40(2-3):167-71. PubMed ID: 9610481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methods of studying alpha 2-antiplasmin activity].
    Boiadzhiian KhP
    Vopr Med Khim; 1991; 37(5):92-4. PubMed ID: 1722061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the interaction between dextran and the primary fibrinolysis inhibitor alpha 2-antiplasmin.
    Carlin G; Saldeen T
    Thromb Res; 1980 Jul 1-15; 19(1-2):103-10. PubMed ID: 6160633
    [No Abstract]   [Full Text] [Related]  

  • 25. A probe of the human plasmin-alpha 2-macroglobulin interaction utilizing monoclonal antibodies to human plasmin.
    Cummings HS; Castellino FJ
    Ann N Y Acad Sci; 1983; 421():143-8. PubMed ID: 6202187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of a plasminogen activator proteinase, LV-PA with human alpha2-macroglobulin.
    Hermogenes AL; Richardson M; Magalhaes A; Yarleque A; Rodriguez E; Sanchez EF
    Toxicon; 2006 Mar; 47(4):490-4. PubMed ID: 16458339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis.
    Oda T; Tamura K; Yoshizawa N; Sugisaki T; Matsumoto K; Hattori M; Sawai T; Namikoshi T; Yamada M; Kikuchi Y; Suzuki S; Miura S
    Nephrol Dial Transplant; 2008 Jul; 23(7):2254-9. PubMed ID: 18223261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kallikrein inhibition of the expression of the lymphocyte E rosette receptor. Prevention of this effect by alpha-2-macroglobulin].
    Hainaut J; Joussemet M; Nicolas J
    C R Acad Sci III; 1985; 301(15):675-7. PubMed ID: 2416406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin.
    Harpel PC
    J Exp Med; 1977 Oct; 146(4):1033-40. PubMed ID: 70499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of tumor cell motility by plasmin.
    Chikahisa L; Matsuo K; Yamada Y
    Invasion Metastasis; 1997; 17(6):323-33. PubMed ID: 9949291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmin/alpha2-antiplasmin complexes (PAP) in lung cancer patients: effects of radiotherapy.
    Uszyński M; Ziółkowska E; Zekanowska E; Uszyński W
    Thromb Haemost; 2002 Jul; 88(1):169-70. PubMed ID: 12152666
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of factors regulating the ageing of human erythrocytes-IV. Influence of physiological proteinase inhibitors.
    Bocci V; Pessina GP; Paulesu L
    Int J Biochem; 1981; 13(12):1257-60. PubMed ID: 6172299
    [No Abstract]   [Full Text] [Related]  

  • 34. [Plasmin-alpha 2-antiplasmin complexes in blood of patient with lichen planus against the background of other fibrinolysis parameters].
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Zwolska A
    Pol Merkur Lekarski; 2003 Jul; 15(85):72-4. PubMed ID: 14593965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mechanism of binding of serpins and serine proteases.
    Longstaff C; Gaffney PJ
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):89-97. PubMed ID: 1377955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 37. On the utility of assays of plasmin-alpha 2-antiplasmin complex in rheumatic and inflammatory diseases.
    Nilsson TK
    Scand J Rheumatol; 1990; 19(5):383-4. PubMed ID: 1699268
    [No Abstract]   [Full Text] [Related]  

  • 38. Mediators of fibrinolysis in orthotopic liver transplantation.
    Cheema SP; Webster NR; Dunn F; Bellamy MC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Change in levels of plasmin and its inhibitors in blood of patients with dyscirculatory encephalopathy before and after the treatment].
    Izmaĭlova NA; Zorina RM; Shvets EK; Belogolova KM
    Klin Lab Diagn; 2009 Aug; (8):32-4. PubMed ID: 19827195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of collagenolysis and cell death by plasmin within the formative stigma of preovulatory ovine follicles.
    Murdoch WJ
    J Reprod Fertil; 1998 Jul; 113(2):331-6. PubMed ID: 9861174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.